|
Kidney Cancer Cases
Case 1: Light cell kidney adenocarcinoma
pathology with metastasis
Name: Jorge Lindh
Age: 56 years old
Country: Sweden
Reason of consultation:
11/21/2001 Left nefrectomized patient in 1998 by a malignant
kidney pathology. He underwent surgery in Sweden, resulting
a light cell adenocarcinoma.
Personal antecedents:
No antecedents to remark.
Family antecedents:
We ignore them.
Present disease antecedents:
It was thought at the first place that the neoplasy
had been taken definitively, a year later, after two
checkings that did not show any anomaly, shortly after
the third checking, in July, 2001, he had a thorax additional
tomography. At that moment metastasis in both lungs
were discovered. Lymphatic metastasis in left and right
lung which oppress both the tracheas and the esophagus.
Later on it was discovered an additional metastasis
in the left kidney post-surgery lay and behind the right
clavicle. He consults about the possibility of treating
himself with our medicament.
11/21/2001 The treatment is initiated with 30 drops
4 times per day of the medicament, for fifteen days,
then 40 drops 4 times per day.
Disease evolution:
Patient who was treated only with our medicament by
his own will.
01/27/2002 He expresses well being due to the intake
of the medicament. He does not have swallowing difficulties
because of the compression that the metastasis from
both lungs made on the esophagus and the tracheas.
02/28/2002 The metastasis on the left kidney surgery
lay has stopped its growth.
The metastasis behind right clavicle also stopped its
growth.
The lungs metastasis which oppressed tracheas and esophagus
only have grown 10,14 mm, he does not have swallowing
difficulties.
03/14/2002 He comes to consult in Montevideo, subjectively
and objectively well.
He maintained his weight. Normal kidney functionality.
Marginal tumor growth, it is increased to 50 drops 4
times per day.
The patient improves his life quality, he can perform
a normal life ambulatory, he goes on with 50 drops 4
times per day having his next control in May.
He is asymptomatic in clinic cure and is released with
a maintenance GREEN SAP dosage.
Conclusions:
Patient of 56 years old, left kidnectomized in 1998
due to a malignant kidney pathology (light cell kidney
adenocarcinoma), surgery in Sweden. In July, 2001, there
were metastasis discovered by thorax tomography, in
both lungs. Lymphatic metastasis in left and right lung.
Metastasis which oppress both the tracheas and the esophagus.
Later on it was discovered an additional metastasis
in the left kidney post-surgery lay and another one
behind the right clavicle.
11/21/2001: He initiates the treatment with 30 drips
4 times per day. He begins with evident improvement,
corroborated by exams. He received only GREEN SAP treatment,
by his own will. He improves his swallowing capability.
He improves his breathing capacity. Very good general
state.
03/14/2002: He comes to Montevideo, subjectively and
objectively fine. There are no doubts left about the
beneficial action to a great level of GREEN SAP medicament,
as the patient is in clinic cure and on release. It
is doubtless that the medication has had a remarkable
anti-tumor effect, with characteristics that equals
the most ancient and experienced drugs by other colleagues.
GREEN SAP action is not accidentally as we mentioned
in GREEN SAP Action on kidney neoplasies (see page 89).
This action was observed throughout the years and the
experience that is given by its use, which also fills
with satisfaction both us and the people who use it.
Case 2: Light cell adenocarcinoma
and hypernefroma
Name: Jorge Antonio Suárez
Age: 51 years old
Country: Argentina
Reason of consultation:
12/27/2001 Left kidnectomized in 1994 due to hypernefroma.
Asymptomatic until March, 2001.
Personal antecedents:
No personal antecedents to remark.
Family antecedents:
No family antecedents to remark.
Present disease antecedents:
Asymptomatic patient until March, 2001 when he presents
a left iliac fossa tumor, he has a biopsy done which
shows a light cell carcinoma.
Clinically asymptomatic.
Computerized tomography: right supra-kidney gland metastasis.
Nodular lesion in contact with the posterior side of
the lower cava vein. Nodular lesions that compromise
the psoas muscle.
He had a computerized tomography of the facial cranium
structure done, which was normal.
Neck computerized tomography: normal.
Thorax computerized tomography: nodular image of soft
parts density of approximately 15 mm in maximum left
posterior intercostals diameter which would have to
be evaluated following the antecedents.
Pelvic abdominal computerized tomography: it were explored
the pelvic and abdominal regions, after the intake of
oral contrast substance to dye the digestive tube and
the injection of contrast substances intravenously.
Discrete diffuse hypo-density of the liver parenchyma
compatible with slight infiltration. Nodular images
compatible with metastasis in the right supra-kidney
gland. The biggest of them of approximately 35 mm. It
is also observed nodular lesion in contact with the
lateral side of the lower cava vein immediately above
the right kidney vein. Sequel of left kidnectomy, being
identified the pancreas tail and the lower pole of the
spleen at the kidney fosse. It is observed nodular lesion
in the upper pole of the right kidney. The gall bladder
does not show any alteration. The left supra-kidney
gland is not identifiable. Nodular lesion with cystic
and/or necrotic center coming from the front area of
the left psoas muscle. It can also be observed nodular
confluent lesions with soft parts density which involve
the left iliac psoas muscle. It is also identified a
nodular lesion in the right internal obturator muscle.
Comment: The described lesions in the thorax and specially
in the abdominal-pelvic region are compatible in first
place with metastasis.
Disease evolution:
He initiated the treatment with the medicament in November,
2001, with 45 drops 4 times per day. After a month he
continued with 50 drops. Next month 60 drops 4 times
per day.
04/03/2002: Clinically asymptomatic. Kidney carcinoma
Stage IV. Tomographic improvement of his lesions in
February, 2002.
He goes on with 60 drops every 6 hours sublingually.
08/28/2002: Patient stable, he keeps on asymptomatic
and with good survival. He performs daily activities.
He feeds well. He sleeps well. Conserved digestive transit.
Urinary transit: no major alterations.
04/11/2003: In clinic cure, on release with maintenance
GREEN SAP dosage.
Conclusions:
Patient of 51 years old, left kidnectomized. Asymptomatic,
until March, 2001. In March, 2001 presents a left iliac
fosse tumor which shows in the biopsy Light Cell Carcinoma.
He also presents in the computerized tomography a nodular
image with soft parts density of 15 mm. of intercostals
maximum diameter.
Lesions compatible with metastasis in the right supra-kidney
gland.
He initiated treatment whit the medicament in November,
2001, quickly evolutioning both clinic and imagenologically.
The GREEN SAP’ mechanism of action on the kidney
tumors and its metastasis manifested once more leading
the patient to the clinic cure and his release. Maintaining
a control dosage with the medicament.
This patient is in healthy state, what we attribute
to the use of GREEN SAP, which has acted as we have
been seen for years, in an excellent way. GREEN SAP
is a therapeutic weapon of first level and our patients
are our witnesses of the seriousness with what we face
our work with them and we believe that this medicament
is a fundamental contribution to the contemporary medicine.
Case 3: Kidney cancer
Name: Irma Renoldi
Age: 65 years old
Country: Argentina
Reason of consultation:
03/19/2002 She consults due to retro-peritoneal tumoration.
Personal antecedents:
Without personal antecedents to remark.
Family antecedents:
None to remark.
Present disease antecedents:
She begins with lower limbs edema a month ago reason
why she underwent exams. The abdominal ultrasonography
and abdominal-pelvic and thoracic CAT show a left kidney
mass. The CAT informs retroperitoneal mass that measures
5,1 cm. That seems to originate in the back valve of
the left upper pole extending to the medial area getting
in touch with the diaphragm and also with the left kidney
vein. The bone centellogram does not show metastasis.
The treatment with the medicament is initiated taking
40 drops 4 times per day.
Disease evolution:
06/05/2002 – Clinic and paraclinic improvement.
Awaiting new paraclinic studies. Anyway the improvement
of the patient’s life quality is impressive. She
goes on with 40 drops 4 times per day.
08/21/2002 - She comes to consult. She does not bring
CAT but confirms us complete reducing of the tumor mass.
Asymptomatic.
We maintain 40 drops 4 times per day sublingually. We
maintain such dosage until December, 2002.
At the present moment, due to the complete reducing
of the tumor mass and the excellent clinic and paraclinic
state we release her with proved clinic cure, maintaining
basal dosage of the medicament during a month, once
a year.
Conclusions:
Patient of 65 years old, who consults because of a retroperitoneal
tumoration. The CAT shows retroperitoneal mass which
measures 5,1 cm., that seems to originate in the back
valve of the left upper pole, extending to the medial
sector getting in touch with the diaphragm and also
with the sub-renal gland. It also contacts the kidney
vein.
She initiates the treatment taking 40 drops 4 times
per day. GREEN SAP, due to the explained mechanisms
in the kidney anti-tumor action, acted in a quick and
effective way, achieving the patient’s clinic
cure and her release, who presented a voluminous and
related to other structures in the vicinity, kidney
tumor.
GREEN SAP stopped the tumor kinetic, leading the patient
towards a healthy state that more expensive medicaments
and with more disgusting collateral effects and medicament
interactions do not achieve in a indolent way, that
is without suffering as our medicament does which has
the back up of the cases in which it has achieved complete
remissions, clinic cures and over all, what more interests
us, an excellent life quality that allows the patient
to develop from a physical point of view in a completely
normal way, what psychologically benefits him in a superlative
way, this being many times forgotten by the traditional
medicine, but we keep in mind every day focusing the
patient as a whole.
GREEN SAP deserves a stand up position among the medications
which fight malignant diseases and make so without causing
collateral effects, which many times in traditional
medicine oblige to give up the treatment, which in a
very high percentage of cases this does not happen to
us, also establishing through GREEN SAP an actual friendship
with the patient, what encourages him to go on and achieve
the cure as in this case, in which this medication was
used.
|
